CVS Caremark to cover Foundayo, Zepbound obesity drugs
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
America Forever Bytes
CVS Caremark · AFBytes
Company
CVS Caremark
Recent coverage
CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lill...